Vivos Therapeutics, Inc. (VVOS)
0.0569
-0.02
(-25.13%)
USD |
NASDAQ |
Nov 19, 16:00
0.0567
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Shareholders Equity (Quarterly) : 2.36M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.36M |
| June 30, 2026 | -3.815M |
| March 31, 2026 | -1.138M |
| December 31, 2025 | -1.49M |
| September 30, 2025 | 2.532M |
| June 30, 2025 | 4.583M |
| March 31, 2025 | 4.407M |
| December 31, 2024 | 7.954M |
| September 30, 2024 | 7.665M |
| June 30, 2024 | 6.347M |
| March 31, 2024 | 0.582M |
| December 31, 2023 | 0.411M |
| September 30, 2023 | 0.046M |
| June 30, 2023 | 2.106M |
| Date | Value |
|---|---|
| March 31, 2023 | 6.993M |
| December 31, 2022 | 4.801M |
| September 30, 2022 | 9.855M |
| June 30, 2022 | 14.84M |
| March 31, 2022 | 21.04M |
| December 31, 2021 | 25.54M |
| September 30, 2021 | 32.47M |
| June 30, 2021 | 36.48M |
| March 31, 2021 | 14.34M |
| December 31, 2020 | 16.92M |
| September 30, 2020 | -0.0097M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -1.626M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hinge Health, Inc. | 299.42M |
| Exlites Holdings International, Inc. | 0.338M |
| Xcelerate, Inc. | -2.140M |
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.86M |
| Total Liabilities (Quarterly) | 20.69M |
| Debt to Equity Ratio | 2.538 |
| Current Ratio | 0.217 |
| Net Debt Paydown Yield | 22.36% |